Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer (PRIMUS)

Sponsor and Collaborators     
Biothera

Contact
Terri Gaffney     
513.579.9911 ext 2593     
[email protected]


Continue Reading

Investigator    
Biothera

ClinicalTrials.gov Identifier

NCT01309126